89 related articles for article (PubMed ID: 16061222)
1. The cyclopentenone 15-deoxy-delta(12,14)-prostaglandin J2 inhibits G1/S transition and retinoblastoma protein phosphorylation in immortalized lymphocytes from Alzheimer's disease patients.
Muñoz U; de Las Cuevas N; Bartolomé F; Hermida OG; Bermejo F; Martín-Requero A
Exp Neurol; 2005 Oct; 195(2):508-17. PubMed ID: 16061222
[TBL] [Abstract][Full Text] [Related]
2. HMG-CoA reductase inhibitor simvastatin inhibits cell cycle progression at the G1/S checkpoint in immortalized lymphocytes from Alzheimer's disease patients independently of cholesterol-lowering effects.
Sala SG; Muñoz U; Bartolomé F; Bermejo F; Martín-Requero A
J Pharmacol Exp Ther; 2008 Jan; 324(1):352-9. PubMed ID: 17928568
[TBL] [Abstract][Full Text] [Related]
3. 15-deoxy-Delta12,14 prostaglandin J2 up-regulates Kruppel-like factor 4 expression independently of peroxisome proliferator-activated receptor gamma by activating the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signal transduction pathway in HT-29 colon cancer cells.
Chen ZY; Tseng CC
Mol Pharmacol; 2005 Nov; 68(5):1203-13. PubMed ID: 16077033
[TBL] [Abstract][Full Text] [Related]
4. 15-Deoxy-Delta12,14-prostaglandin J2 inhibits IL-1beta-induced cyclooxygenase-2 expression in mesangial cells.
Sawano H; Haneda M; Sugimoto T; Inoki K; Koya D; Kikkawa R
Kidney Int; 2002 Jun; 61(6):1957-67. PubMed ID: 12028436
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of IFN-γ-induced B7-H1 expression by 15-deoxy-delta(12,14)-prostaglandin J2 via downregulation of the Jak/STAT/IRF-1 signaling pathway.
Seo SK; Seo DI; Park WS; Jung WK; Lee DS; Park SG; Choi JS; Kang MS; Choi YH; Choi I; Yu BC; Choi IW
Life Sci; 2014 Sep; 112(1-2):82-9. PubMed ID: 25072357
[TBL] [Abstract][Full Text] [Related]
6. Contrasting effects of peroxisome-proliferator-activated receptor (PPAR)gamma agonists on membrane-associated prostaglandin E2 synthase-1 in IL-1beta-stimulated rat chondrocytes: evidence for PPARgamma-independent inhibition by 15-deoxy-Delta12,14prostaglandin J2.
Bianchi A; Moulin D; Sebillaud S; Koufany M; Galteau MM; Netter P; Terlain B; Jouzeau JY
Arthritis Res Ther; 2005; 7(6):R1325-37. PubMed ID: 16277686
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of 15-deoxy-delta(12,14)-prostaglandin J2 and a peroxisome proliferator-activated receptor gamma agonist on macrophage activation.
Guyton K; Bond R; Reilly C; Gilkeson G; Halushka P; Cook J
J Leukoc Biol; 2001 Apr; 69(4):631-8. PubMed ID: 11310850
[TBL] [Abstract][Full Text] [Related]
8. 15-deoxy-Delta12, 14-prostaglandin J2 activates the expression of p15INK4b gene, a cyclin-dependent kinase inhibitor.
Matsuzaki Y; Koyama M; Hitomi T; Takaoka Y; Kawanaka M; Sakai T
Int J Oncol; 2005 Aug; 27(2):497-503. PubMed ID: 16010433
[TBL] [Abstract][Full Text] [Related]
9. 15-Deoxy-delta12,14-PGJ2 inhibits IL-6-induced Stat3 phosphorylation in lymphocytes.
Kim HJ; Rho YH; Choi SJ; Lee YH; Cheon H; Um JW; Sohn J; Song GG; Ji JD
Exp Mol Med; 2005 Jun; 37(3):179-85. PubMed ID: 16000871
[TBL] [Abstract][Full Text] [Related]
10. PPAR gamma ligands, 15-deoxy-delta12,14-prostaglandin J2 and rosiglitazone regulate human cultured airway smooth muscle proliferation through different mechanisms.
Ward JE; Gould H; Harris T; Bonacci JV; Stewart AG
Br J Pharmacol; 2004 Feb; 141(3):517-25. PubMed ID: 14718259
[TBL] [Abstract][Full Text] [Related]
11. On the mechanism of inhibition of p27 degradation by 15-deoxy-Delta12,14-prostaglandin J2 in lymphoblasts of Alzheimer's disease patients.
Muñoz U; Bartolomé F; Esteras N; Bermejo-Pareja F; Martín-Requero A
Cell Mol Life Sci; 2008 Nov; 65(21):3507-19. PubMed ID: 18818877
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor gamma ligands, 15-deoxy-Delta12,14-prostaglandin J2, and ciglitazone, induce growth inhibition and cell cycle arrest in hepatic oval cells.
Cheng J; Nakamura H; Imanishi H; Liu W; Morisaki T; Sugiyama T; Hada T
Biochem Biophys Res Commun; 2004 Sep; 322(2):458-64. PubMed ID: 15325252
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor gamma is required for the inhibitory effect of ciglitazone but not 15-deoxy-Delta 12,14-prostaglandin J2 on the NFkappaB pathway in human endothelial cells.
Kaplan J; Cook JA; O'Connor M; Zingarelli B
Shock; 2007 Dec; 28(6):722-726. PubMed ID: 17621259
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor-gamma ligands inhibit proliferation and induce apoptosis in mantle cell lymphoma.
Eucker J; Sterz J; Krebbel H; Zavrski I; Kaiser M; Zang C; Heider U; Jakob C; Elstner E; Sezer O
Anticancer Drugs; 2006 Aug; 17(7):763-9. PubMed ID: 16926626
[TBL] [Abstract][Full Text] [Related]
15. 15d-Prostaglandin J2 activates peroxisome proliferator-activated receptor-gamma, promotes expression of catalase, and reduces inflammation, behavioral dysfunction, and neuronal loss after intracerebral hemorrhage in rats.
Zhao X; Zhang Y; Strong R; Grotta JC; Aronowski J
J Cereb Blood Flow Metab; 2006 Jun; 26(6):811-20. PubMed ID: 16208315
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of IL-10-induced STAT3 activation by 15-deoxy-Delta12,14-prostaglandin J2.
Ji JD; Kim HJ; Rho YH; Choi SJ; Lee YH; Cheon HJ; Sohn J; Song GG
Rheumatology (Oxford); 2005 Aug; 44(8):983-8. PubMed ID: 15840591
[TBL] [Abstract][Full Text] [Related]
17. 15-Deoxy-Δ12,14-prostaglandin J2 induces PPARγ- and p53-independent apoptosis in rabbit synovial cells.
Sakaba Y; Awata H; Morisugi T; Kawakami T; Sakudo A; Tanaka Y
Prostaglandins Other Lipid Mediat; 2014 Jun; 109-111():1-13. PubMed ID: 24680891
[TBL] [Abstract][Full Text] [Related]
18. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer.
Lin MS; Chen WC; Bai X; Wang YD
J Dig Dis; 2007 May; 8(2):82-8. PubMed ID: 17532820
[TBL] [Abstract][Full Text] [Related]
19. 15-Deoxy-Delta12,14-prostaglandin J2 enhances docetaxel anti-tumor activity against A549 and H460 non-small-cell lung cancer cell lines and xenograft tumors.
Fulzele SV; Chatterjee A; Shaik MS; Jackson T; Ichite N; Singh M
Anticancer Drugs; 2007 Jan; 18(1):65-78. PubMed ID: 17159504
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
Grau R; Iñiguez MA; Fresno M
Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]